NUVL Nuvalent Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NUVL

Price (delayed)

$63.61

Market cap

$4.08B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$2.17

Enterprise value

$3.74B

Highlights
The equity has surged by 77% since the previous quarter and by 51% year-on-year
NUVL's quick ratio has soared by 59% since the previous quarter but it is down by 7% year-on-year
Nuvalent's net income has shrunk by 54% YoY and by 11% QoQ
The EPS has contracted by 32% YoY and by 6% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: EA TTWO

Key stats

What are the main financial stats of NUVL
Market
Shares outstanding
64.07M
Market cap
$4.08B
Enterprise value
$3.74B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.69
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$126.22M
EBITDA
-$126.22M
Free cash flow
-$99.74M
Per share
EPS
-$2.17
Free cash flow per share
-$1.71
Book value per share
$11.19
Revenue per share
$0
TBVPS
$12.58
Balance sheet
Total assets
$732.38M
Total liabilities
$31.82M
Debt
$0
Equity
$700.56M
Working capital
$694.67M
Liquidity
Debt to equity
0
Current ratio
22.83
Quick ratio
22.62
Net debt/EBITDA
2.66
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-24.5%
Return on equity
-25.7%
Return on invested capital
-36.7%
Return on capital employed
-18%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

NUVL stock price

How has the Nuvalent stock price performed over time
Intraday
0.87%
1 week
-2.9%
1 month
-18.53%
1 year
92.64%
YTD
-13.56%
QTD
-15.29%

Financial performance

How have Nuvalent's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$149.49M
Net income
-$126.22M
Gross margin
N/A
Net margin
N/A
The operating income has dropped by 74% year-on-year and by 13% since the previous quarter
Nuvalent's net income has shrunk by 54% YoY and by 11% QoQ

Growth

What is Nuvalent's growth rate over time

Valuation

What is Nuvalent stock price valuation
P/E
N/A
P/B
5.69
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has contracted by 32% YoY and by 6% from the previous quarter
The equity has surged by 77% since the previous quarter and by 51% year-on-year

Efficiency

How efficient is Nuvalent business performance
The ROIC has increased by 15% year-on-year
The ROA has increased by 4.7% YoY and by 2.8% QoQ
Nuvalent's return on equity has increased by 4.1% YoY and by 3% QoQ

Dividends

What is NUVL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NUVL.

Financial health

How did Nuvalent financials performed over time
The total assets has soared by 72% since the previous quarter and by 52% year-on-year
The total liabilities has surged by 63% year-on-year and by 9% since the previous quarter
The debt is 100% smaller than the equity
The equity has surged by 77% since the previous quarter and by 51% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.